Revenue, consisting of revenue from collaborative research, was $0.0 million the three months ended March 31, 2019, compared to $0.2 million for the same period in 2018. Revenue decreased as no research activities were performed under collaboration agreements for the three month period in 2019. Cash, cash equivalents and short-term investments were $189.5 million as of March 31, 2019, compared to $205.1 million as of December 31, 2018. Adverum expects this quarter-end cash position to fund operations into 2021.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.